- Home
- BDSX vs LTRX Comparison
BDSX vs LTRX Comparison
Compare BDSX & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- LTRX
- Stock Information
- Founded
- BDSX 2005
- LTRX 1989
- Country
- BDSX United States
- LTRX United States
- Employees
- BDSX N/A
- LTRX N/A
- Industry
- BDSX Precision Instruments
- LTRX Computer Communications Equipment
- Sector
- BDSX Health Care
- LTRX Telecommunications
- Exchange
- BDSX Nasdaq
- LTRX Nasdaq
- Market Cap
- BDSX 115.4M
- LTRX 106.5M
- IPO Year
- BDSX 2020
- LTRX 2000
- Fundamental
- Price
- BDSX $0.35
- LTRX $2.27
- Analyst Decision
- BDSX Strong Buy
- LTRX Strong Buy
- Analyst Count
- BDSX 4
- LTRX 5
- Target Price
- BDSX $2.83
- LTRX $5.80
- AVG Volume (30 Days)
- BDSX 523.2K
- LTRX 211.4K
- Earning Date
- BDSX 05-13-2025
- LTRX 05-08-2025
- Dividend Yield
- BDSX N/A
- LTRX N/A
- EPS Growth
- BDSX N/A
- LTRX N/A
- EPS
- BDSX N/A
- LTRX N/A
- Revenue
- BDSX $71,323,000.00
- LTRX $155,842,000.00
- Revenue This Year
- BDSX $32.90
- LTRX N/A
- Revenue Next Year
- BDSX $24.65
- LTRX $11.33
- P/E Ratio
- BDSX N/A
- LTRX N/A
- Revenue Growth
- BDSX 45.30
- LTRX 12.96
- 52 Week Low
- BDSX $0.45
- LTRX $1.91
- 52 Week High
- BDSX $2.04
- LTRX $4.55
- Technical
- Relative Strength Index (RSI)
- BDSX 27.69
- LTRX 52.33
- Support Level
- BDSX $0.51
- LTRX $2.10
- Resistance Level
- BDSX $0.58
- LTRX $2.30
- Average True Range (ATR)
- BDSX 0.06
- LTRX 0.10
- MACD
- BDSX -0.01
- LTRX 0.04
- Stochastic Oscillator
- BDSX 1.15
- LTRX 90.63
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.